Literature DB >> 12242546

Idiopathic inflammatory pseudotumor of the orbit and Tolosa-Hunt syndrome--are they the same disease?

C Wasmeier1, K Pfadenhauer, A Rösler.   

Abstract

Unilateral periorbital pain, cranial nerve palsies and a dramatic response to corticosteroid therapy are the hallmarks of clinical presentation in Tolosa-Hunt-Syndrome (THS) and Idiopathic Pseudotumor of the Orbit (IIPO). Both are unspecific chronic granulomatous diseases of unknown origin, sharing clinical as well as paraclinical characteristics. We observed two patients suffering from acute granulomatous IIPO, who also fulfilled the criteria of THS. Patient 1 developed leftsided infiltration of the medial ocular muscle with periorbital pain and cranial nerve palsy. After an initial response to corticosteroid therapy, contralateral relapse occurred with a THS-like infiltration of the sinus cavernosus and narrowing of the intracavernous internal carotid artery. Granulomatous infiltration of the right sinus cavernosus with secondary involvement of the ipsilateral nervus opticus and a slight exophthalmos was seen in Case 2. According to the literature, MRI and CT show identical signal intensity with different localisation: IIPO preferentially intra- and THS retroorbital. Apart from neuroradiological findings, almost similar histopathology and clinical presentation makes it difficult to distinguish between these two syndromes. Similarities between these two syndromes have been discussed for more than 20 years. Our two cases show their close relationship and we suggest that both diseases belong to the same pathological process.

Entities:  

Mesh:

Year:  2002        PMID: 12242546     DOI: 10.1007/s00415-002-0818-x

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  19 in total

1.  Bilateral idiopathic orbital inflammatory syndrome with grossly elevated creatinine kinase levels.

Authors:  W H Chan; S Biswas; J Ashworth; I Hughes; V Sharma; I C Lloyd
Journal:  Eye (Lond)       Date:  2011-12-23       Impact factor: 3.775

Review 2.  Categorization and characterization of lesions of the orbital apex.

Authors:  Saifuddin T Vohra; Edward J Escott; Dale Stevens; Barton F Branstetter
Journal:  Neuroradiology       Date:  2010-05-07       Impact factor: 2.804

3.  Inflammatory myofibroblastic tumor of the orbit with associated enhancement of the meninges and multiple cranial nerves.

Authors:  A M McKinney; J Short; L Lucato; K SantaCruz; Z McKinney; Y Kim
Journal:  AJNR Am J Neuroradiol       Date:  2006 Nov-Dec       Impact factor: 3.825

Review 4.  Inflammatory pseudotumor of the cavernous sinus and skull base.

Authors:  Todd McCall; Daniel R Fassett; George Lyons; William T Couldwell
Journal:  Neurosurg Rev       Date:  2006-03-25       Impact factor: 3.042

Review 5.  Magnetic resonance imaging of orbital tumors.

Authors:  A J Lemke; I Kazi; R Felix
Journal:  Eur Radiol       Date:  2006-04-01       Impact factor: 5.315

Review 6.  An approach to the patient with painful ophthalmoplegia, with a focus on Tolosa-Hunt syndrome.

Authors:  Jonathan P Gladstone
Journal:  Curr Pain Headache Rep       Date:  2007-08

7.  Cavernous Sinus: A Comprehensive Review of its Anatomy, Pathologic Conditions, and Imaging Features.

Authors:  A A Bakan; A Alkan; S Kurtcan; A Aralaşmak; S Tokdemir; E Mehdi; H Özdemir
Journal:  Clin Neuroradiol       Date:  2014-11-20       Impact factor: 3.649

8.  Inflammatory Pseudo-tumour Orbitae (PTO): An Atypical Manifestation of Giant Cell Arteritis (GCA).

Authors:  M Hittinger; A Berlis; K Pfadenhauer
Journal:  Clin Neuroradiol       Date:  2014-09-18       Impact factor: 3.649

9.  Orbital pseudotumor: distinct diagnostic features and management.

Authors:  Imtiaz A Chaudhry; Farrukh A Shamsi; Yonca O Arat; Fenwick C Riley
Journal:  Middle East Afr J Ophthalmol       Date:  2008-01

Review 10.  Orbital inflammation.

Authors:  Kimberly P Cockerham; Sang H Hong; Ellen E Browne
Journal:  Curr Neurol Neurosci Rep       Date:  2003-09       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.